| International Myeloma Working Group molecular classification of multiple myeloma: spotlight review R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ... Leukemia 23 (12), 2210-2221, 2009 | 1181 | 2009 |
| A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance D Chauhan, Z Tian, B Nicholson, KGS Kumar, B Zhou, R Carrasco, ... Cancer cell 22 (3), 345-358, 2012 | 563 | 2012 |
| Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages JL Guerriero, A Sotayo, HE Ponichtera, JA Castrillon, AL Pourzia, ... Nature 543 (7645), 428-432, 2017 | 482 | 2017 |
| Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells T Hideshima, H Ikeda, D Chauhan, Y Okawa, N Raje, K Podar, ... Blood, The Journal of the American Society of Hematology 114 (5), 1046-1052, 2009 | 445 | 2009 |
| Constitutive telomerase expression promotes mammary carcinomas in aging mice SE Artandi, S Alson, MK Tietze, NE Sharpless, S Ye, RA Greenberg, ... Proceedings of the National Academy of Sciences 99 (12), 8191-8196, 2002 | 394 | 2002 |
| Pathogenesis of myeloma KC Anderson, RD Carrasco Annual Review of Pathology: Mechanisms of Disease 6, 249-274, 2011 | 371 | 2011 |
| Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML TT Vo, J Ryan, R Carrasco, D Neuberg, DJ Rossi, RM Stone, ... Cell 151 (2), 344-355, 2012 | 366 | 2012 |
| Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features AK Azab, J Hu, P Quang, F Azab, C Pitsillides, R Awwad, B Thompson, ... Blood, The Journal of the American Society of Hematology 119 (24), 5782-5794, 2012 | 349 | 2012 |
| A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance Z Tian, P D’Arcy, X Wang, A Ray, YT Tai, Y Hu, RD Carrasco, ... Blood, The Journal of the American Society of Hematology 123 (5), 706-716, 2014 | 330 | 2014 |
| Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers F Cottini, T Hideshima, C Xu, M Sattler, M Dori, L Agnelli, E Ten Hacken, ... Nature medicine 20 (6), 599-606, 2014 | 314 | 2014 |
| A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma G Görgün, E Calabrese, T Hideshima, J Ecsedy, G Perrone, M Mani, ... Blood, The Journal of the American Society of Hematology 115 (25), 5202-5213, 2010 | 309 | 2010 |
| Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target D Chauhan, AV Singh, M Brahmandam, R Carrasco, M Bandi, ... Cancer cell 16 (4), 309-323, 2009 | 296 | 2009 |
| Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma SK McBrayer, JR Mayers, GJ DiNatale, DD Shi, J Khanal, AA Chakraborty, ... Cell 175 (1), 101-116. e25, 2018 | 273 | 2018 |
| miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway JJ Zhao, J Lin, D Zhu, X Wang, D Brooks, M Chen, ZB Chu, K Takada, ... Cancer research 74 (6), 1801-1813, 2014 | 202 | 2014 |
| The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia X Leleu, X Jia, J Runnels, HT Ngo, AS Moreau, M Farag, JA Spencer, ... Blood, The Journal of the American Society of Hematology 110 (13), 4417-4426, 2007 | 172 | 2007 |
| Clonal architecture of CXCR4 WHIM‐like mutations in Waldenström Macroglobulinaemia L Xu, ZR Hunter, N Tsakmaklis, Y Cao, G Yang, J Chen, X Liu, S Kanan, ... British journal of haematology 172 (5), 735-744, 2016 | 143 | 2016 |
| P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment AK Azab, P Quang, F Azab, C Pitsillides, B Thompson, T Chonghaile, ... Blood, The Journal of the American Society of Hematology 119 (6), 1468-1478, 2012 | 130 | 2012 |
| Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma T Hideshima, J Qi, RM Paranal, W Tang, E Greenberg, N West, ... Proceedings of the National Academy of Sciences 113 (46), 13162-13167, 2016 | 125 | 2016 |
| Nanoparticles for immune cytokine TRAIL-based cancer therapy PPG Guimarães, S Gaglione, T Sewastianik, RD Carrasco, R Langer, ... ACS nano 12 (2), 912-931, 2018 | 121 | 2018 |
| The Cyclophilin A–CD147 complex promotes the proliferation and homing of multiple myeloma cells DI Zhu, Z Wang, JJ Zhao, T Calimeri, J Meng, T Hideshima, M Fulciniti, ... Nature medicine 21 (6), 572-580, 2015 | 106 | 2015 |
